The present disclosure relates to washing a suspension of cells, and particularly to washing cells with centrifugal force.
This section provides background information related to the present disclosure which is not necessarily prior art.
Blood transfusions are used to treat many disorders and injuries, such as in the treatment of accident victims and during surgical procedures. According to current American Red Cross statistics, about 5 million people receive blood transfusions each year, in the United States alone. Thus, health care systems rely on the collection and distribution of blood. Typically, blood is obtained from a donor and then processed and stored; units of stored blood or blood products are then taken from storage as needed and transfused into a patient in need. In some cases, the blood may be an autologous donation, where an individual donates blood in expectation of receiving his or her own blood by transfusion during a medical procedure.
Donated blood is typically processed into components and then placed in storage until needed. When a subject is in need of a blood transfusion, a unit of blood is commonly removed from storage, rejuvenated, washed, and resuspended in an appropriate solution. In some instances, the red blood cells were lyophilized prior to storage, in which case they need to be resuspended, washed, and then resuspended again in an appropriate solution. The resuspended red blood cells are then transfused into the subject. In either scenario, washing the red blood cells is traditionally a tedious, time consuming and multistep process that requires a great deal of tubing, and the use of expensive centrifuges with rotating seals to separate the cells from the wash solution. Therefore, there remains a need to streamline and simplify the process for washing red blood cells prior to transfusion.
This section provides a general summary of the disclosure, and is not a comprehensive disclosure of its full scope or all of its features.
The present technology provides a device for washing a suspension of cells. The device includes a cylindrical inner wall that extends about and along a longitudinal axis from a first end to a second end that defines a central compartment. The device also includes a cylindrical intermediate wall that extends about and along the axis from the first end to the second end that defines an intermediate compartment. Also, the device has a cylindrical outer wall that extends about and along the axis from the first end to a third end that defines an outer wall. The central, intermediate, and outer compartments are concentric. Additionally, a first valve is positioned through the first inner wall near the second end such that the central compartment is in fluid communication with the intermediate compartment when the valve is open. An aperture or second valve is positioned through the second inner wall near the first end such that the intermediate compartment is in fluid communication with the outer compartment continuously or when the second valve is open. First and second inlets are positioned on the first end and are in communication with the center and intermediate compartments, respectively. An outlet is positioned on the first end and is in communication with the outer compartment.
Another device for washing a suspension of cells is also provided. The device has an annular intermediate wall extending about and along a longitudinal axis from a first surface to a second opposing surface; an annular inner wall extending about and along the axis from the first surface to the second surface; and an annular outer wall extending about and along the axis from the first surface to a third surface that extends outwardly and orthogonally from the intermediate wall. The annular inner wall defines a first central compartment, and the annular intermediate and outer walls define a second intermediate compartment and a third outer compartment. The first, second and third compartments are concentric. First and second inlets are positioned on the first end and are in communication with the center and intermediate compartments, respectively. An outlet is positioned on the first end and is in communication with the outer compartment.
Also, the present technology provides a method for washing a suspension of cells. The method includes introducing a suspension of cells into a central cylindrical compartment of a device for washing cells. The suspension of cells includes a suspension fluid and a plurality of cells. The method further includes introducing a wash solution into an annular intermediate compartment of the device, wherein the intermediate compartment is adjacent to the central compartment, and wherein the central compartment is separated from the intermediate compartment by a valve. Then, the method includes rotating the device about a central longitudinal axis such that the wash solution is forced outward through an aperture and into an annular outer compartment, wherein the outer compartment is adjacent to the intermediate compartment. The method then includes opening the valve, separating the cells from the suspension fluid, isolating the cells, and collecting the cells.
Further areas of applicability will become apparent from the description provided herein. The description and specific examples in this summary are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.
The drawings described herein are for illustrative purposes only of selected embodiments and not all possible implementations, and are not intended to limit the scope of the present disclosure.
Corresponding reference numerals indicate corresponding parts throughout the several views of the drawings.
Example embodiments will now be described more fully with reference to the accompanying drawings.
The present technology generally provides devices and methods for washing a suspension of cells. The devices and methods rely on centripetal force to pass “dirty” cells through a wash solution. The cells are then isolated from the wash solution as “clean cells”. Accordingly, the devices according to the present technology do not require much, if any, tubing. Rotating seals are not required in the device and the only movements necessary are spinning of a rotor and opening of at least one valve as described in detail below. The devices provide quick and easy methods for washing a suspension of cells, which, for example, can be administered to a human or other animal subject in need thereof.
The devices can be used to separate a component from a multicomponent mixture. For example, cells can be separated from a multicomponent mixture in order to separate the cells from at least one unwanted component, which results in washed cells. Different types of cells are often treated with various compositions, which results in a need to separate the cells from treatment solutions and particulate matter, such as cell fragments and cellular debris. According to the present technology, cells can be washed in any wash solution known in the art. However, in various embodiments the wash solution is not less dense than the fluid in which the cells are suspended. In other embodiments, the wash solution is denser than the fluid in which the cells are suspended. Non-limiting examples of wash solutions include water, saline, dextrose, saline with 5% dextrose, phosphate buffered saline, and other solution that are used to remove unwanted components from cells. The cells may then be administered to a subject, such as a human or non-human mammal, or otherwise manipulated or stored. Non-limiting examples of cells that can be treated and washed include cells in whole blood, red blood cells, platelets, adipocytes, chondrocytes, and mixtures thereof. For example, because stored red blood cells (RBCs) have a diminished capacity to oxygenate tissues, a suspension of RBCs removed from storage can be rejuvenated by adding an enhancement composition, such as Rejuvesol® Red Blood Cell Processing Solution (Citra Labs, LLC, Braintree, Mass.), to the RBCs to form a multicomponent mixture or a suspension of cells. The suspension of cells including rejuvenated RBCs and a wash solution are then introduced into a device provided herein, wherein the RBCs are washed. During the wash, the RBCs are separated and isolated from the enhancement composition and optionally from unwanted cellular debris. The RBCs can then be used as concentrated RBCs or they can be resuspended in a reconstitution solution to achieve a desired RBC concentration.
Methods
With reference to
As shown in block 14, the method 10 also includes introducing a wash solution into an annular intermediate compartment of the device, wherein the intermediate compartment is adjacent to the central compartment. The central compartment is separated from the intermediate compartment by a first valve. In various embodiments, introducing a wash solution to the intermediate compartment comprises introducing a wash solution selected from the group consisting of water, saline, dextrose, saline with 5% dextrose, and phosphate buffered saline into the intermediate compartment. In some embodiments, the wash solution has a density equal to or greater than the density of a fluid in which the cells to be washed are suspended. This density requirement enables the cells in the suspension to move from the suspension fluid to the wash solution with minimal mixing of the suspension fluid with the wash solution.
The method 10 also comprises rotating the device radially about a central longitudinal axis at a first speed to generate a first centripetal force, as shown in block 16. In some embodiments, the first centripetal force that causes the wash to move outward and into an annular outer compartment that is adjacent to the intermediate compartment by way of an aperture, opening, or optional second valve. When the second valve is present, it is actuated mechanically or by a predetermined centripetal force, such as the first centripetal force. In yet other embodiments, introducing the wash solution to the device includes introducing a sufficient volume of wash solution to fill the intermediate and outer compartments, which are in fluid communication through an aperture or opening. In such embodiments, the first centripetal force has a minimal effect on how the wash solution is distributed between the intermediate and outer compartments.
As shown in blocks 18 and 20, the method 10 also comprises opening the valve and separating the plurality of cells from the suspension fluid. Opening the valve occurs when the device is rotated to a second speed that generates a second centripetal force. In various embodiments, the valve is positioned such that the cells move out of the suspension fluid in the central compartment and enter the intermediate compartment at a lower end. Because the wash solution has a density equal to or greater than the density of the suspension fluid, a minimal amount of suspension fluid should enter the intermediate compartment. The cells are forced through the wash solution in the intermediate compartment and upward toward the aperture, opening, or optional second valve. By being separated from the suspension fluid and traveling through the wash solution, the cells are washed and become “clean”.
As shown in block 22, the method 10 then comprises isolating the washed cells. Isolating the washed cells occurs when the cells travel through the aperture, opening, or optional second valve and into the outer compartment. The cells have a density that is greater than the density of the wash solution. Therefore, as the cells enter the outer compartment, they displace the wash solution, which is forced through the aperture, opening, or optional second valve in an opposite direction of the cells to enter the intermediate compartment. This displacement may also cause a portion of the wash solution in the intermediate compartment to enter the central compartment through the valve separating the compartments. Isolating is complete when all the cells have entered the outer compartment and the outer compartment contains a minimal volume or no wash solution. Then, rotation of the device is stopped, and as shown in block 24, the method 10 includes collecting the cells through an outlet that is in fluid communication with the outer compartment.
Devices
With reference to
The device 100 also comprises a first cylindrical inner wall 118 that extends about and along the axis 104 from the first end 106 to the second end 108. The first inner wall 118 contacts the first end 106 at the first inner surface 110 and the second end 108 at the second inner surface 114. The first inner wall 118 defines a first central compartment 120. Also, the device 100 comprises a second intermediate cylindrical inner wall 122 that extends about and along the axis 104 from the first end 106 to the second end 108. The second intermediate inner wall 122 contacts the first end 106 at the first inner surface 110 and the second end 108 at the second inner surface 114 and is positioned between the inner wall 118 and the outer wall 102 and defines an intermediate annular compartment 124 and an outer annular compartment 126. The central compartment 120, the intermediate compartment 124, and the outer compartment 126 are concentric.
In various embodiments, the first end 106 and the second end 108 are separated by a distance H1 with respect to the central, intermediate and outer compartments 120, 124, 126. In other words, the inner wall 118, intermediate wall 122, and outer wall 102 each extend a distance H1 from the first end 106 to the second end 108. In other embodiments, the first end 106 and second end 108 are separated by a distance H1 with respect to the central and intermediate compartments 120, 124 and by a distance of H2 with respect to the outer compartment 126, wherein H1 is greater than H2. In other words, the inner and intermediate walls 118, 122 both extend a distance H1 from the first end 106 to the second end 108 and the outer wall extends a distance H2 from the first end 106 to the third end 128. In such embodiments, the third end 128 extends outwardly and optionally orthogonally from the intermediate wall 122 to the outer wall 102 to define the outer compartment 126. In various embodiments, H2 is from about 95% the height of H1 to about 5% the height of H1. For example, H2 can be about 95% (about 19/20), about 90% (about 9/10), about 80% (about ⅘), about 75% (about ¾), about 66% (about ⅔), about 50% (about ½), about 40% (about ⅖), about 33% (about ⅓), about 25% (about ¼), about 20% (about ⅕), about 10% (about 1/10), or about 5% (about 1/20) the height of H1. When the second end 108 and the third end 128 are equidistant from the first end 106, i.e., both at a distance H1 from the first end 106, the second end 108 and third end 128 are equivalent and there may be little or no distinction between the second and third ends 108, 128. In any embodiment, the volume of the inner compartment 120 is equal to or greater than the volume of the outer compartment 126, such that the outer compartment can receive all or a majority of cells loaded in the first compartment 120, as described further below.
The device 100 also includes a first valve 132 positioned in or through the inner wall 118 at or near the second inner surface 114 of the second end 108. In various embodiments, the device 100 comprises a plurality of first valves 132. The central and intermediate compartments are in fluid communication with each other when the first valve 132 is open. The first valve 132 is configured to open mechanically or centripetally at a predetermined centripetal force. In various embodiments, the first valve 132 opens when the device 100 is spun at a speed of from about 500 to about 3000 rpm, or from about 1000 to about 2000 rpm. In one embodiment, the first valve opens when the device is spun at a speed of at least about 500 rpm. Non-limiting examples of valves that are actuated by centripetal force and that are suitable for the first valve 132 are described in U.S. Pat. No. 7,824,559 issued to Dorian et al. on Aug. 10, 20016, and U.S. Pat. No. 7,708,152 issued to Dorian et al. on May 4, 2010, both of which are incorporated herein by reference.
The device 100 also includes an aperture, opening, or second valve 134 positioned in or through the intermediate wall 122 at or near the first inner surface 110 of the first end 106 to establish an optionally controllable fluid communication between the intermediate and outer compartments 124, 126. In various embodiments, the device 100 comprises a plurality of apertures, openings, or second valves 134. In other embodiments, the aperture, opening, or second valve 134 is an annular and continuous opening that provides continuous and uninterrupted fluid communication between the intermediate and outer compartments. In yet other embodiments, the aperture, opening, or second valve 134 comprises a second valve that establishes fluid communication between the intermediate and outer compartments 124, 126, which is controlled by actuating the valve to an open position. In such embodiments, the second valve 134 is configured to open mechanically or at a predetermined centripetal force. In various embodiments, the second valve 134 opens when the device 100 is spun at a speed of from about 500 to about 3000 rpm, or from about 1000 to about 2000 rpm. In one embodiment, the first valve opens when the device is spun at a speed of at least about 500 rpm. Non-limiting examples of valves that are actuated by centripetal force and that are suitable for the second valve 134 are described in U.S. Pat. No. 7,824,559 issued to Dorian et al. on Aug. 10, 20016, and U.S. Pat. No. 7,708,152 issued to Dorian et al. on May 4, 2010, both of which are incorporated herein by reference.
As shown in
Referring back to
Additionally, the device 100 comprises a first vent 144, a second vent 146, and a third vent 148 that are in communication with the central compartment 120, intermediate compartment 124, and outer compartment 126, respectively. The vents 144, 146, 148 permit air to escape the respective compartments 120, 124, 126 as they become filled with wash solution, a suspension of cells, cell, or a mixture thereof. In some embodiments (not shown) the vents are integrated into the inlets and outlet such that separate inlets, outlets, and vents are not required. Moreover, the inlets, outlet, vents, or combinations thereof (inlet/vent or outlet/vent) can be positioned at the first end 106 such that the device is balanced when rotating radially about the axis 104.
The devices 100, 100′ are configured to be received by a base unit 160 that comprises a rotor. When engaged with the base unit 160, the base unit 160 is capable of spinning the devices 100, 100′ about the axis 16 at various speeds to generate various centripetal forces.
Methods for Using the Devices
With reference to
The method also includes introducing or loading a wash solution 206 into the intermediate compartment 124 of the device 100 via the second inlet 138 until at least the intermediate compartment 124 is full of wash solution 206. In one embodiment, the intermediate and outer compartments 124, 126 are in continuous fluid communication with each other via the aperture, opening, or second valve 134 such that loading is performed until both the intermediate and outer compartments 124, 126 are filled with the wash solution 206. As described above, non-limiting examples of suitable wash solutions include water, saline, dextrose, saline with 5% dextrose, phosphate buffered saline. Nonetheless, in one embodiment, the wash solution 206 can be any solution that has a density equal to or greater than the density of the suspension fluid 202. Loading the suspension of cells 200 and wash solution 206 can be performed by any method known in the art, such as, for example, by injecting with a syringe or by pumping the suspension 200 and wash solution 206 individually through a conduit that is coupled to the inlets 136, 138.
With reference to
As shown in
As the device 100 continues to rotate, the cells 204 continue to be forced through the wash solution 206 in the intermediate compartment 124, where the cells 204 become washed. Then the method includes isolating the washed cells 204 as the cells 204 pass through the aperture, opening, or second valve 134 and enter the outer compartment 126. As the cells 204 enter the outer compartment 126, the cells 204 displace the wash solution 206 that is present in the outer compartment 126 and forces the wash solution 206 through the aperture, opening, or second valve 134 in a direction opposite to that of the cells 204 and back into the intermediate compartment 124. By forcing the wash solution 206 out of the outer compartment 126, the washed cells 204 are isolated.
With reference to
Definitions
Although the terms first, second, third, etc. may be used herein to describe various elements, components, regions, layers and/or sections, these elements, components, regions, layers and/or sections should not be limited by these terms. These terms may be only used to distinguish one element, component, region, layer or section from another region, layer or section. Terms such as “first,” “second,” and other numerical terms when used herein do not imply a sequence or order unless clearly indicated by the context. Thus, a first element, component, region, layer or section discussed below could be termed a second element, component, region, layer or section without departing from the teachings of the example embodiments.
The terminology used herein is for the purpose of describing particular example embodiments only and is not intended to be limiting. As used herein, the singular forms “a,” “an,” and “the” may be intended to include the plural forms as well, unless the context clearly indicates otherwise. The terms “comprises,” “comprising,” “including,” and “having,” are inclusive and therefore specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof. The method steps, processes, and operations described herein are not to be construed as necessarily requiring their performance in the particular order discussed or illustrated, unless specifically identified as an order of performance. It is also to be understood that additional or alternative steps may be employed.
The foregoing description of the embodiments has been provided for purposes of illustration and description. It is not intended to be exhaustive or to limit the disclosure. Individual elements or features of a particular embodiment are generally not limited to that particular embodiment, but, where applicable, are interchangeable and can be used in a selected embodiment, even if not specifically shown or described. The same may also be varied in many ways. Such variations are not to be regarded as a departure from the disclosure, and all such modifications are intended to be included within the scope of the disclosure.
Number | Name | Date | Kind |
---|---|---|---|
3141846 | Laven, Jr. | Jul 1964 | A |
3409165 | Creith | Nov 1968 | A |
3420374 | Umeda | Jan 1969 | A |
3441143 | Kudlaty | Apr 1969 | A |
3453364 | Flodin et al. | Jul 1969 | A |
3469369 | Helmke | Sep 1969 | A |
3508653 | Coleman | Apr 1970 | A |
3593915 | Steinacker | Jul 1971 | A |
3647070 | Adler | Mar 1972 | A |
3779383 | Ayres | Dec 1973 | A |
3785549 | Latham, Jr. | Jan 1974 | A |
3814248 | Lawhead | Jun 1974 | A |
3850369 | Bull et al. | Nov 1974 | A |
3879295 | Glover et al. | Apr 1975 | A |
3894952 | Ayres | Jul 1975 | A |
3897343 | Ayres | Jul 1975 | A |
3909419 | Ayres | Sep 1975 | A |
3929646 | Adler | Dec 1975 | A |
3931010 | Ayres et al. | Jan 1976 | A |
3931018 | North, Jr. | Jan 1976 | A |
3935113 | Ayres | Jan 1976 | A |
3941699 | Ayres | Mar 1976 | A |
3972812 | Gresl, Jr. | Aug 1976 | A |
3982691 | Schlutz | Sep 1976 | A |
4001122 | Griffin | Jan 1977 | A |
4046699 | Zine, Jr. | Sep 1977 | A |
4055501 | Cornell | Oct 1977 | A |
4059108 | Latham, Jr. | Nov 1977 | A |
4077396 | Wardlaw et al. | Mar 1978 | A |
4152270 | Cornell | May 1979 | A |
4159896 | Levine et al. | Jul 1979 | A |
4187979 | Cullis et al. | Feb 1980 | A |
4204537 | Latham, Jr. | May 1980 | A |
4225580 | Rothman et al. | Sep 1980 | A |
4229298 | Bange | Oct 1980 | A |
4269718 | Persidsky | May 1981 | A |
4294707 | Ikeda et al. | Oct 1981 | A |
4298598 | Schwarz et al. | Nov 1981 | A |
4300717 | Latham, Jr. | Nov 1981 | A |
4303193 | Latham, Jr. | Dec 1981 | A |
4314823 | Rich, Jr. et al. | Feb 1982 | A |
4322298 | Persidsky | Mar 1982 | A |
4332351 | Kellogg et al. | Jun 1982 | A |
4362567 | Schwarz et al. | Dec 1982 | A |
4364832 | Ballies et al. | Dec 1982 | A |
4377572 | Schwarz et al. | Mar 1983 | A |
4414976 | Schwarz et al. | Nov 1983 | A |
4416654 | Schoendorfer et al. | Nov 1983 | A |
4417981 | Nugent | Nov 1983 | A |
4424132 | Iriguchi | Jan 1984 | A |
4427650 | Stroetmann et al. | Jan 1984 | A |
4427651 | Stroetmann et al. | Jan 1984 | A |
4442655 | Stroetmann | Apr 1984 | A |
4446021 | Aufderhaar et al. | May 1984 | A |
4453939 | Zimmerman et al. | Jun 1984 | A |
4464167 | Schoendorfer et al. | Aug 1984 | A |
4537767 | Rothman et al. | Aug 1985 | A |
RE32089 | Blatt et al. | Mar 1986 | E |
4610656 | Mortensen | Sep 1986 | A |
4617009 | Ohlin et al. | Oct 1986 | A |
4627879 | Rose et al. | Dec 1986 | A |
4631055 | Redl et al. | Dec 1986 | A |
4632761 | Bowers et al. | Dec 1986 | A |
4639316 | Eldegheidy | Jan 1987 | A |
4650678 | Fuhge et al. | Mar 1987 | A |
4655211 | Sakamoto et al. | Apr 1987 | A |
4672969 | Dew | Jun 1987 | A |
4675117 | Neumann et al. | Jun 1987 | A |
4680025 | Kruger et al. | Jul 1987 | A |
4714457 | Alterbaum | Dec 1987 | A |
4722790 | Cawley et al. | Feb 1988 | A |
4724317 | Brown et al. | Feb 1988 | A |
4735616 | Eibl et al. | Apr 1988 | A |
4735726 | Duggins | Apr 1988 | A |
4738655 | Brimhall et al. | Apr 1988 | A |
4755300 | Fischel et al. | Jul 1988 | A |
4755301 | Bowers | Jul 1988 | A |
4770779 | Ichikawa et al. | Sep 1988 | A |
4776964 | Schoendorfer et al. | Oct 1988 | A |
4818291 | Iwatsuki et al. | Apr 1989 | A |
4818386 | Burns | Apr 1989 | A |
4828710 | Itoh et al. | May 1989 | A |
4832851 | Bowers et al. | May 1989 | A |
4834890 | Brown et al. | May 1989 | A |
4839058 | Cawley et al. | Jun 1989 | A |
4844818 | Smith | Jul 1989 | A |
4846780 | Galloway et al. | Jul 1989 | A |
4846974 | Kelley et al. | Jul 1989 | A |
4853137 | Ersson | Aug 1989 | A |
4859333 | Panzani | Aug 1989 | A |
4871462 | Fischel et al. | Oct 1989 | A |
4874368 | Miller et al. | Oct 1989 | A |
4877520 | Burns | Oct 1989 | A |
4879031 | Panzani et al. | Nov 1989 | A |
4900453 | Sedlmayer et al. | Feb 1990 | A |
4902281 | Avoy | Feb 1990 | A |
4928603 | Rose et al. | May 1990 | A |
4929242 | Desecki et al. | May 1990 | A |
4933291 | Daiss et al. | Jun 1990 | A |
4943273 | Pages et al. | Jul 1990 | A |
4946601 | Fiehler | Aug 1990 | A |
4950220 | Wells et al. | Aug 1990 | A |
4957638 | Smith | Sep 1990 | A |
4983157 | Pober et al. | Jan 1991 | A |
4983158 | Headley | Jan 1991 | A |
4985153 | Kuroda et al. | Jan 1991 | A |
5000970 | Shanbhag et al. | Mar 1991 | A |
5002571 | O'Donnell, Jr. et al. | Mar 1991 | A |
5019243 | McEwen et al. | May 1991 | A |
5030215 | Morse et al. | Jul 1991 | A |
5030341 | McEwen et al. | Jul 1991 | A |
5045048 | Kaleskas et al. | Sep 1991 | A |
5053127 | Schoendorfer et al. | Oct 1991 | A |
5071570 | Shiraki et al. | Dec 1991 | A |
5100564 | Pall et al. | Mar 1992 | A |
5104375 | Wolf et al. | Apr 1992 | A |
5112484 | Zuk, Jr. | May 1992 | A |
5112490 | Turpen | May 1992 | A |
5131907 | Williams et al. | Jul 1992 | A |
5137832 | Levine et al. | Aug 1992 | A |
5141645 | Shiraki et al. | Aug 1992 | A |
5147290 | Jonsson et al. | Sep 1992 | A |
5152905 | Pall et al. | Oct 1992 | A |
5156613 | Sawyer | Oct 1992 | A |
5165938 | Knighton | Nov 1992 | A |
5171456 | Hwang et al. | Dec 1992 | A |
5173295 | Wehling et al. | Dec 1992 | A |
5185001 | Galanakis | Feb 1993 | A |
5188583 | Guigan et al. | Feb 1993 | A |
5190057 | Sarfarazi | Mar 1993 | A |
5190759 | Lindblad et al. | Mar 1993 | A |
5204537 | Bennet et al. | Apr 1993 | A |
5206023 | Hunziker | Apr 1993 | A |
5217426 | Bacehowski et al. | Jun 1993 | A |
5217627 | Pall et al. | Jun 1993 | A |
5219328 | Morse et al. | Jun 1993 | A |
5226877 | Epstein | Jul 1993 | A |
5234608 | Duff | Aug 1993 | A |
5236604 | Fiehler | Aug 1993 | A |
5258126 | Pall et al. | Nov 1993 | A |
5260420 | Burnouf-Radosevich et al. | Nov 1993 | A |
5269927 | Fiehler | Dec 1993 | A |
5271852 | Luoma, II | Dec 1993 | A |
5279825 | Wehling et al. | Jan 1994 | A |
5281342 | Biesel et al. | Jan 1994 | A |
5290552 | Sierra et al. | Mar 1994 | A |
5290918 | Bui-Khac et al. | Mar 1994 | A |
5298171 | Biesel et al. | Mar 1994 | A |
5304372 | Michalski et al. | Apr 1994 | A |
5316674 | Pall et al. | May 1994 | A |
5318524 | Morse et al. | Jun 1994 | A |
5318782 | Weis-Fogh et al. | Jun 1994 | A |
5321126 | van Dommelen et al. | Jun 1994 | A |
5322620 | Brown et al. | Jun 1994 | A |
5330974 | Pines et al. | Jul 1994 | A |
5344752 | Murphy | Sep 1994 | A |
5370802 | Brown | Dec 1994 | A |
5376263 | Fischel | Dec 1994 | A |
5387187 | Fell et al. | Feb 1995 | A |
5393674 | Levine et al. | Feb 1995 | A |
5395923 | Bui-Khac et al. | Mar 1995 | A |
5403272 | Deniega et al. | Apr 1995 | A |
5405607 | Epstein | Apr 1995 | A |
5411885 | Marx | May 1995 | A |
5417650 | Gordon | May 1995 | A |
5420250 | Lontz | May 1995 | A |
5443481 | Lee | Aug 1995 | A |
5454958 | Fiehler | Oct 1995 | A |
5456693 | Conston et al. | Oct 1995 | A |
5456885 | Coleman et al. | Oct 1995 | A |
5480378 | Weis-Fogh et al. | Jan 1996 | A |
5484383 | Fitch, Jr. et al. | Jan 1996 | A |
5494578 | Brown et al. | Feb 1996 | A |
5494592 | Latham, Jr. et al. | Feb 1996 | A |
5505685 | Antwiler | Apr 1996 | A |
5510102 | Cochrum | Apr 1996 | A |
5533518 | Vogler | Jul 1996 | A |
5560830 | Coleman et al. | Oct 1996 | A |
5577513 | Van Vlasselaer | Nov 1996 | A |
5585007 | Antanavich et al. | Dec 1996 | A |
5589462 | Patat et al. | Dec 1996 | A |
5601727 | Bormann et al. | Feb 1997 | A |
5607579 | Latham, Jr. et al. | Mar 1997 | A |
5614106 | Payrat et al. | Mar 1997 | A |
5632905 | Haynes | May 1997 | A |
5641622 | Lake et al. | Jun 1997 | A |
5643192 | Hirsh et al. | Jul 1997 | A |
5643193 | Papillon et al. | Jul 1997 | A |
5674173 | Hlavinka et al. | Oct 1997 | A |
5733545 | Hood, III | Mar 1998 | A |
5736033 | Coleman et al. | Apr 1998 | A |
5762798 | Wenthold et al. | Jun 1998 | A |
5788662 | Antanavich et al. | Aug 1998 | A |
5795489 | Holm et al. | Aug 1998 | A |
5795571 | Cederholm-Williams et al. | Aug 1998 | A |
5853600 | McNeal et al. | Dec 1998 | A |
5860937 | Cohen | Jan 1999 | A |
5889584 | Wardlaw | Mar 1999 | A |
5918622 | Perez et al. | Jul 1999 | A |
5924972 | Turvaville et al. | Jul 1999 | A |
5934803 | Hutter | Aug 1999 | A |
5958253 | Holm et al. | Sep 1999 | A |
5980757 | Brown et al. | Nov 1999 | A |
6011490 | Tonnesen et al. | Jan 2000 | A |
6022306 | Dumont et al. | Feb 2000 | A |
6025201 | Zelmanovic et al. | Feb 2000 | A |
6027655 | Holm | Feb 2000 | A |
6051146 | Green et al. | Apr 2000 | A |
6053856 | Hlavinka | Apr 2000 | A |
6054122 | MacPhee et al. | Apr 2000 | A |
6063297 | Antanavich et al. | May 2000 | A |
6071423 | Brown et al. | Jun 2000 | A |
6090793 | Zimmermann et al. | Jul 2000 | A |
6096309 | Prior et al. | Aug 2000 | A |
6102843 | Kelley et al. | Aug 2000 | A |
6117425 | MacPhee et al. | Sep 2000 | A |
6153113 | Goodrich et al. | Nov 2000 | A |
6196987 | Holmes et al. | Mar 2001 | B1 |
6197325 | MacPhee et al. | Mar 2001 | B1 |
6200287 | Keller et al. | Mar 2001 | B1 |
6214338 | Antanavich et al. | Apr 2001 | B1 |
6245900 | Yamasaki et al. | Jun 2001 | B1 |
6274090 | Coelho et al. | Aug 2001 | B1 |
6277961 | Hock et al. | Aug 2001 | B1 |
6280400 | Niermann | Aug 2001 | B1 |
6296602 | Headley | Oct 2001 | B1 |
6316247 | Katz et al. | Nov 2001 | B1 |
6322785 | Landesberg et al. | Nov 2001 | B1 |
6334842 | Hlavinka et al. | Jan 2002 | B1 |
6342157 | Hood, III | Jan 2002 | B1 |
6368298 | Beretta et al. | Apr 2002 | B1 |
6464624 | Pages | Oct 2002 | B2 |
6472162 | Coelho et al. | Oct 2002 | B1 |
6516953 | DiCesare et al. | Feb 2003 | B1 |
6544162 | Van Wie et al. | Apr 2003 | B1 |
6563953 | Lin et al. | May 2003 | B2 |
6596180 | Baugh et al. | Jul 2003 | B2 |
6629919 | Egozy et al. | Oct 2003 | B2 |
6676629 | Andrew et al. | Jan 2004 | B2 |
6758978 | Bedell | Jul 2004 | B1 |
6764531 | Hogan | Jul 2004 | B2 |
6777231 | Katz et al. | Aug 2004 | B1 |
6830762 | Baugh et al. | Dec 2004 | B2 |
6905612 | Dorian et al. | Jun 2005 | B2 |
6979307 | Beretta et al. | Dec 2005 | B2 |
7011644 | Andrew et al. | Mar 2006 | B1 |
7077273 | Ellsworth et al. | Jul 2006 | B2 |
7179391 | Leach et al. | Feb 2007 | B2 |
7694828 | Swift et al. | Apr 2010 | B2 |
7708152 | Dorian et al. | May 2010 | B2 |
7824559 | Dorian et al. | Nov 2010 | B2 |
7901584 | Dorian et al. | Mar 2011 | B2 |
7987995 | Dorian et al. | Aug 2011 | B2 |
8096422 | Dorian et al. | Jan 2012 | B2 |
8105495 | Dorian et al. | Jan 2012 | B2 |
8133389 | Dorian et al. | Mar 2012 | B2 |
20020032112 | Pages | Mar 2002 | A1 |
20020076400 | Katz et al. | Jun 2002 | A1 |
20030082152 | Hedrick et al. | May 2003 | A1 |
20030191429 | Andrew et al. | Oct 2003 | A1 |
20040171146 | Katz et al. | Sep 2004 | A1 |
20040182788 | Dorian et al. | Sep 2004 | A1 |
20040182795 | Dorian et al. | Sep 2004 | A1 |
20040251217 | Leach et al. | Dec 2004 | A1 |
20050076396 | Katz et al. | Apr 2005 | A1 |
20050084961 | Hedrick et al. | Apr 2005 | A1 |
20050109716 | Leach et al. | May 2005 | A1 |
20050153441 | Hedrick et al. | Jul 2005 | A1 |
20050153442 | Katz et al. | Jul 2005 | A1 |
20050196874 | Dorian et al. | Sep 2005 | A1 |
20050247715 | Ellsworth et al. | Nov 2005 | A1 |
20050260174 | Fraser et al. | Nov 2005 | A1 |
20050260175 | Hedrick et al. | Nov 2005 | A1 |
20050282275 | Katz et al. | Dec 2005 | A1 |
20060083720 | Fraser et al. | Apr 2006 | A1 |
20060175242 | Dorian et al. | Aug 2006 | A1 |
20060175244 | Dorian et al. | Aug 2006 | A1 |
20060196885 | Leach et al. | Sep 2006 | A1 |
20060243676 | Swift et al. | Nov 2006 | A1 |
20070036768 | Fraser et al. | Feb 2007 | A1 |
20070075016 | Leach | Apr 2007 | A1 |
20080011684 | Dorian et al. | Jan 2008 | A1 |
20080283474 | Leach et al. | Nov 2008 | A1 |
20090289014 | Hoeppner | Nov 2009 | A1 |
20100206798 | Dorian et al. | Aug 2010 | A1 |
20100226909 | Hecker et al. | Sep 2010 | A1 |
20140047986 | Robinson | Feb 2014 | A1 |
20160332158 | Leach et al. | Nov 2016 | A1 |
Number | Date | Country |
---|---|---|
696278 | Jan 1999 | AU |
9103724 | Mar 1993 | BR |
1321138 | Aug 1993 | CA |
2182862 | Jun 1996 | CA |
1074709 | Jul 1993 | CN |
56103 | Oct 1860 | DE |
1443359 | Nov 1968 | DE |
3321466 | Dec 1983 | DE |
4202667 | May 1993 | DE |
090997 | Oct 1983 | EP |
0097455 | Jan 1984 | EP |
0102773 | Mar 1984 | EP |
0109374 | May 1984 | EP |
0142339 | May 1985 | EP |
0253198 | Jan 1988 | EP |
0272915 | Jun 1988 | EP |
285891 | Oct 1988 | EP |
0295771 | Dec 1988 | EP |
0295771 | Dec 1988 | EP |
0417818 | Mar 1991 | EP |
0534178 | Mar 1993 | EP |
0592242 | Apr 1994 | EP |
1005910 | Jun 2000 | EP |
1427279 | Jun 2004 | EP |
1467746 | Oct 2004 | EP |
1670315 | Jun 2006 | EP |
1716901 | Nov 2006 | EP |
854715 | Nov 1960 | GB |
60-053845 | Mar 1985 | JP |
60250014 | Dec 1985 | JP |
63182055 | Jul 1988 | JP |
6454256 | Apr 1989 | JP |
2036872 | Feb 1990 | JP |
02071747 | Mar 1990 | JP |
04500170 | Jan 1992 | JP |
6250014 | Sep 1994 | JP |
09187504 | Jul 1997 | JP |
9509432 | Sep 1997 | JP |
11502502 | Mar 1999 | JP |
2000117150 | Apr 2000 | JP |
02129224 | Oct 2000 | JP |
2001017540 | Jan 2001 | JP |
2005523128 | Aug 2005 | JP |
246078 | May 2007 | MX |
WO-8400905 | Mar 1984 | WO |
WO-8802259 | Apr 1988 | WO |
WO-8901827 | Mar 1989 | WO |
WO-9010031 | Sep 1990 | WO |
WO-9222312 | Dec 1992 | WO |
WO-9305067 | Mar 1993 | WO |
WO-9308904 | May 1993 | WO |
WO-9407548 | Apr 1994 | WO |
WO-9616714 | Jun 1996 | WO |
WO-9617871 | Jun 1996 | WO |
WO-9848938 | Nov 1998 | WO |
WO-0103756 | Jan 2001 | WO |
WO-0183068 | Nov 2001 | WO |
WO-0224107 | Mar 2002 | WO |
WO-03015800 | Feb 2003 | WO |
WO-03024215 | Mar 2003 | WO |
WO-03053362 | Jul 2003 | WO |
WO-03092894 | Nov 2003 | WO |
WO-03090839 | Nov 2003 | WO |
WO-2004009207 | Jan 2004 | WO |
WO-2004037427 | May 2004 | WO |
WO-2004104553 | Dec 2004 | WO |
WO-2005034843 | Apr 2005 | WO |
WO-2006081699 | Aug 2006 | WO |
WO-2007142908 | Dec 2007 | WO |
WO-2011008836 | Jan 2011 | WO |
WO-2016160451 | Oct 2016 | WO |
WO-2016182830 | Nov 2016 | WO |
Entry |
---|
“International Application Serial No. PCT/US2016/023762, International Search Report mailed Jun. 16, 2016”, 4 pgs. |
“International Application Serial No. PCT/US2016/023762, Written Opinion mailed Jun. 16, 2016”, 5 pgs. |
“U.S. Appl. No. 14/708,547, Non Final Office Action mailed Jan. 25, 2017”, 8 pgs. |
“U.S. Appl. No. 14/708,547, Non Final Office Action mailed Dec. 16, 2016”, 9 pgs. |
“U.S. Appl. No. 14/708,547, Response filed May 11, 2016 to Restriction Requirement mailed Mar. 11, 2016”, 10 pgs. |
“U.S. Appl. No. 14/708,547, Response filed Sep. 23, 2016 to Restriction Requirement mailed Jul. 28, 2016”, 6 pgs. |
“U.S. Appl. No. 14/708,547, Restriction Requirement mailed Mar. 11, 2016”, 8 pgs. |
“U.S. Appl. No. 14/708,547, Restriction Requirement mailed Jul. 28, 2016”, 6 pgs. |
“International Application Serial No. PCT/US2016/030880, International Search Report mailed Oct. 5, 2016”, 7 pgs. |
“International Application Serial No. PCT/US2016/030880, Invitation to Pay Additional Fees and Partial Search Report mailed Aug. 12, 2016”, 6 pgs. |
“International Application Serial No. PCT/US2016/030880, Written Opinion mailed Oct. 5, 2016”, 9 pgs. |
Number | Date | Country | |
---|---|---|---|
20160288139 A1 | Oct 2016 | US |